These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 37341420)
1. The Impact of Medicare Low-income Subsidy on Access to Treatment, Treatment Choice, and Oncologic Outcomes in Patients With Metastatic Prostate Cancer. Joyce DD; Qin X; Sharma V; Boorjian SA; Barocas DA; Dusetzina SB; Moses KA J Urol; 2023 Sep; 210(3):447-453. PubMed ID: 37341420 [TBL] [Abstract][Full Text] [Related]
2. Affordability and adherence gains for Medicare Part D low-income subsidy recipients when low-income subsidy benefits expanded in 2024. Stuart BC; Loh FE; Dougherty JS J Manag Care Spec Pharm; 2024 Jul; 30(7):728-735. PubMed ID: 38950158 [TBL] [Abstract][Full Text] [Related]
3. Association between insurance cost-sharing subsidy and postoperative opioid prescription refills among Medicare patients. Kirsch M; Montgomery JR; Hu HM; Englesbe M; Hallstrom B; Brummett CM; Fendrick AM; Waljee JF Surgery; 2020 Aug; 168(2):244-252. PubMed ID: 32505547 [TBL] [Abstract][Full Text] [Related]
4. Association between low-income subsidies and inequities in orally administered antimyeloma therapy use. Jazowski SA; Samuel-Ryals CA; Wood WA; Zullig LL; Trogdon JG; Dusetzina SB Am J Manag Care; 2023 May; 29(5):246-254. PubMed ID: 37229783 [TBL] [Abstract][Full Text] [Related]
5. Adherence and out-of-pocket costs among Medicare beneficiaries who are prescribed oral targeted therapies for advanced prostate cancer. Caram MEV; Oerline MK; Dusetzina S; Herrel LA; Modi PK; Kaufman SR; Skolarus TA; Hollenbeck BK; Shahinian V Cancer; 2020 Dec; 126(23):5050-5059. PubMed ID: 32926427 [TBL] [Abstract][Full Text] [Related]
6. Cancer outcomes in low-income elders: is there an advantage to being on Medicaid? Koroukian SM; Bakaki PM; Owusu C; Earle CC; Cooper GS Medicare Medicaid Res Rev; 2012; 2(2):. PubMed ID: 24800139 [TBL] [Abstract][Full Text] [Related]
7. The Association Between Medicare Low-Income Subsidy and Anticancer Treatment Uptake in Advanced Lung Cancer. Chou YT; Farley JF; Stinchcombe TE; Proctor AE; Lafata JE; Dusetzina SB J Natl Cancer Inst; 2020 Jun; 112(6):637-646. PubMed ID: 31501872 [TBL] [Abstract][Full Text] [Related]
8. The unintended effects of the Medicare Part D low income subsidy. Decarolis F Health Policy; 2015 May; 119(5):597-603. PubMed ID: 25716285 [TBL] [Abstract][Full Text] [Related]
9. The relationship between the low-income subsidy and cost-related nonadherence to drug therapies in Medicare Part D. Wei II; Lloyd JT; Shrank WH J Am Geriatr Soc; 2013 Aug; 61(8):1315-23. PubMed ID: 23889465 [TBL] [Abstract][Full Text] [Related]
10. Out-of-Pocket Cost Burden Associated With Contemporary Management of Advanced Prostate Cancer Among Commercially Insured Patients. Joyce DD; Sharma V; Jiang DH; Van Houten HK; Sangaralingham LR; Borah BJ; Kwon ED; Penson DF; Dusetzina SB; Tilburt JC; Boorjian SA J Urol; 2022 Nov; 208(5):987-996. PubMed ID: 36094864 [TBL] [Abstract][Full Text] [Related]
11. Examining initial treatment and survival among men with metastatic prostate cancer: An analysis from the CaPSURE registry. Borno HT; Cowan JE; Zhao S; Broering JM; Carroll PR; Ryan CJ Urol Oncol; 2020 Oct; 38(10):793.e1-793.e11. PubMed ID: 32782182 [TBL] [Abstract][Full Text] [Related]
12. Utilization and costs of medications associated with CKD mineral and bone disorder in dialysis patients enrolled in Medicare Part D. Yusuf AA; Howell BL; Powers CA; St Peter WL Am J Kidney Dis; 2014 Nov; 64(5):770-80. PubMed ID: 24833203 [TBL] [Abstract][Full Text] [Related]
13. The Medicare drug benefit: update on the low-income subsidy. Stahlman ME Issue Brief George Wash Univ Natl Health Policy Forum; 2009 Jul; (833):1-22. PubMed ID: 19685590 [TBL] [Abstract][Full Text] [Related]
14. The effect of out-of-pocket costs on initiation of disease-modifying therapies among medicare beneficiaries with multiple sclerosis. Hartung DM; Johnston KA; McGregor JC; Bourdette DN Mult Scler Relat Disord; 2020 Nov; 46():102554. PubMed ID: 33032059 [TBL] [Abstract][Full Text] [Related]
15. How Low-Income Subsidy Recipients Respond to Medicare Part D Cost Sharing. Stuart B; Hendrick FB; Xu J; Dougherty JS Health Serv Res; 2017 Jun; 52(3):1185-1206. PubMed ID: 27324201 [TBL] [Abstract][Full Text] [Related]
16. Cancer history, insurance coverage, and cost-related medication nonadherence in Medicare beneficiaries, 2013-2018. Li M; Bounthavong M J Manag Care Spec Pharm; 2021 Dec; 27(12):1750-1756. PubMed ID: 34818087 [No Abstract] [Full Text] [Related]
17. Cognition and take-up of subsidized drug benefits by Medicare beneficiaries. Kuye IO; Frank RG; McWilliams JM JAMA Intern Med; 2013 Jun; 173(12):1100-7. PubMed ID: 23649604 [TBL] [Abstract][Full Text] [Related]
18. Association of individual low-income status and area deprivation with mortality in multiple myeloma. Hong YD; Mullins CD; Onukwugha E; Yared JA; Zheng Z; Slejko JF J Geriatr Oncol; 2023 Mar; 14(2):101415. PubMed ID: 36773537 [TBL] [Abstract][Full Text] [Related]
19. Association of Bone Mineral Density Testing With Risk of Major Osteoporotic Fractures Among Older Men Receiving Androgen Deprivation Therapy to Treat Localized or Regional Prostate Cancer. Suarez-Almazor ME; Pundole X; Cabanillas G; Lei X; Zhao H; Elting LS; Lopez-Olivo MA; Giordano SH JAMA Netw Open; 2022 Apr; 5(4):e225432. PubMed ID: 35363269 [TBL] [Abstract][Full Text] [Related]
20. Eligibility and take-up of the Medicare Part D low-income subsidy. Shoemaker JS; Davidoff AJ; Stuart B; Zuckerman IH; Onukwugha E; Powers C Inquiry; 2012; 49(3):214-30. PubMed ID: 23230703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]